Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07659132
PHASE4

Fospropofol Disodium Versus Propofol for Patient Satisfaction in Ureteroscopy

Sponsor: Shiyou Wei

View on ClinicalTrials.gov

Summary

This single-center single-blind randomized trial compares fospropofol disodium and propofol for anesthesia in elective ureteroscopy patients. A total of 190 eligible adults will be randomly divided into two groups at 1:1 ratio with identical intraoperative maintenance protocols. The primary outcome is 24-hour postoperative anesthesia satisfaction assessed by ISAS scale; secondary and safety endpoints include injection pain, intraoperative hemodynamic events and various perioperative adverse reactions. This study explores the clinical efficacy and safety of the two sedatives to guide rational clinical medication.

Official title: Fospropofol Disodium Versus Propofol on Patient Satisfaction in Patients Undergoing Ureteroscopy:A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

190

Start Date

2026-06-26

Completion Date

2026-09-26

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Fospropofol disodium plus sufentanil for anesthesia induction

Intravenous injection of fospropofol disodium combined with sufentanil for anesthesia induction before ureteroscopic surgery. Intraoperative anesthetic maintenance, muscle relaxants and postoperative supportive treatment are consistent with the propofol control group to eliminate intergroup confounding factors.

DRUG

Propofol plus sufentanil for anesthesia induction

Intravenous injection of conventional propofol combined with sufentanil for anesthesia induction before ureteroscopic surgery. All intraoperative and postoperative auxiliary treatment regimens are identical to the fospropofol disodium experimental group